Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas

Journal of Primary Health Care

Volumn 2, Issue 4, 2010, Pages 268-272

  Rademaker, Marius ^a   Oakley, Amanda ^a  

^a WAIKATO HOSPITAL   (New Zealand)

Author keywords

Dermoscopy; Diagnosis; Mass screening; Melanoma; Teledermatology; Telemedicine

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; EARLY DIAGNOSIS; EPILUMINESCENCE MICROSCOPY; EVALUATION; FEMALE; HUMAN; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; NEW ZEALAND; PATHOLOGY; PHOTOGRAPHY; PRIMARY HEALTH CARE; REGISTER; SKIN TUMOR; TIME; WHOLE BODY IMAGING;

ADULT; AGED; DERMOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEW ZEALAND; PHOTOGRAPHY; PRIMARY HEALTH CARE; REGISTRIES; SKIN NEOPLASMS; TIME FACTORS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 79952277249     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc10268     Document Type: Article

References (24)

1. Cancer society of new Zealand Position statement on skin Cancer and Early detection 2006. http://www.cancernz.org.nz/reducing-your-cancer-risk/sunsmart/early-detection-of-skin-cancer/early-detection-for-health-professionals/(accessed december 3rd 2009).
2. The Cancer Council Australia. national Cancer Prevention Policy 2007-09. 2007. NSW, The Cancer Council Australia.
3. Us Preventive services Task Force. screening for skin cancer: recommendations and rationale. Am J Prev Med. 2001;20(3 Suppl):44-6.
4. Koh HK, norton LA, Geller AC, et al. Evaluation of the American Academy of dermatology's national skin Cancer Early detection and screening Program. J Am Acad dermatol. 1996;34:971-8.
5. Geller AC, Zhang Z, sober AJ, et al. The first 15 years of the American Academy of dermatology skin cancer screening programs: 1985-1999. J Am Acad dermatol. 2003;48:34-41.
6. Clinical Practice Guidelines for the Management of Melanoma in Australia and new Zealand. The Cancer Council Australia and Australian Cancer network, sydney and New Zealand Guidelines Group, Wellington; 2008. http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm?guidelineCatid=7&guidelineid=141 (accessed on 2/2/2010)
7. Tan E, Yung A, Jameson M, Oakley A, Rademaker M. successful triage of patients referred to a skin lesion clinic using teledermoscopy (iMAGE iT trial). Br J 2010 Mar 5. [Epub ahead of print]
8. Richardson A, Fletcher L, sneyd MJ, et al. The incidence and thickness of cutaneous malignant melanoma in new Zealand 1994-2004. NZ Med J. 2008;121;18-26.
9. Malvehy J, Puig s, Argenziano G, Marghoob AA, soyer HP; international dermoscopy society Board members. report: proposal for standardization. Results of a consensus meeting of the society. J Am Acad dermatol. 2007;57:84-95.
10. Youl PH, Janda M, Elwood M, et al. Who attends skin cancer clinics within a randomized melanoma screening program? Cancer detect Prev. 2006;30:44-51.
11. Janda M, Elwood M, Ring iT, et al. Prevalence of skin screening by general practitioners in regional queensland. Med J Aust. 2004;180:10-5.
12. Fritschi L, dye sA, Katris P. Validity of melanoma diagnosis in a community-based screening program. Am J Epidemiol. 2006;164:385-90.
13. Aitken JF, Janda M, Elwood M, et al. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad dermatol. 2006;54:105-14.
14. Jonna BP, delfino RJ, newman WG, Tope Wd. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program. Prev Med. 1998;27(4):611-6.
15. De Rooij MJ, Rampen FH, schouten LJ, neumann HA. skin cancer screening focusing on melanoma yields more selective attendance. Arch dermatol. 1995;131:422-5.
16. De Rooij MJ, Rampen FH, LJ, HA. Volunteer melanoma screenings. Follow-up, compliance, and outcome. dermatol surg. 1997;23:197-201.
17. Oakley A, Rademaker M, stewart B. High risk patients self select for melanoma screening. Australas J dermatol. 2009;50 (Suppl 1), A34.
18. McPherson M, Elwood M, English dR, et al. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad 2006;54:783-92.
19. Warycha MA, Christos PJ, Mazumdar M, et al. Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer. 2008;113:3341-8.
20. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust NZ J Public Health. 2005;29:383-6.
21. Haass nK, smalley Ks. Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy. Mol diagn Ther. 2009;13:283-96.
22. Tejera-Vaquerizo A, Barrera-Vigo MV, López-navarro n, Herrera-Ceballos E. Growth rate as a prognostic factor in localized invasive cutaneous melanoma. J Eur Acad dermatol Venereol. 2009 Jul 13.(epub)
23. swetter sM, Johnson TM, Miller dR, et al. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch dermatol. 2009;145:397-404.
24. Geller AC, Elwood M, swetter sM, et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in queensland Australia. Cancer. 2009;115:1318-27.